180 Life Sciences believes acquisition enables continued Nasdaq listing

Management believes that the acquisition of the Gaming Technology Platform enables the Company to satisfy Nasdaq’s continued listing stockholder equity requirement as of September 30, 2024. Nasdaq has provided the Company until October 15, 2024 to complete all public filings which will demonstrate the Company’s compliance with Nasdaq’s stockholder equity requirements. While the Company believes the acquisition has cured the Company’s prior stockholder equity non-compliance, the Company hasn’t yet received official word from Nasdaq regarding such compliance, and Nasdaq could require additional information or continue to deem us in non-compliance, which could result in the delisting of our common stock and warrants at the end of the extended compliance period.